Biogen is discontinuing Alzheimer's medication Aduhelm
Aduhelm is being discontinued by drugmaker Biogen as it shifts resources to its other Alzheimer's medication, Leqembi, and developing other treatments.
Source: nbc-2.com
Page 2 - Aduhelm News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Aduhelm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Aduhelm Today - Breaking & Trending Today
Aduhelm Went From Being Hailed A "Game Changer" To Becoming A Dud
Biogen announced it will discontinue marketing the Alzheimer’s drug Aduhelm. This ends the tortuous saga of a once-promising treatment for the memory-robbing disease.
Source: forbes.com
It's Finally Over for Aduhelm, the Sketchy Alzheimer's Drug Everyone Hated
The FDA approved Biogen's $56,000 anti-amyloid drug in 2021, against the advice of outside experts.
Source: gizmodo.com
Biogen pulls controversial Alzheimer's drug Aduhelm
A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday. It showed a reduction in cognitive decline in one of the studies, but not the other.
Source: yahoo.com
Biogen Says Goodbye to Beleaguered Alzheimer's Drug Aduhelm
Biogen has returned its Aduhelm rights to Neurimmune, the company that initially developed the antibody Alzheimer’s disease drug. But Biogen isn’t abandoning Alzheimer’s, and its pipeline includes drugs that take other approaches to the neurodegenerative disorder.
Source: medcitynews.com